These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35691875)

  • 1. Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema.
    Gündoğdu KÖ; Doğan E; Çelik E; Alagöz G
    J Diabetes Complications; 2022 Jul; 36(7):108228. PubMed ID: 35691875
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of aflibercept and ranibizumab in diabetic macular edema associated with subretinal detachment.
    Ozkaya A; Demir G; Kirmaci A
    Eur J Ophthalmol; 2020 Mar; 30(2):363-369. PubMed ID: 30757913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment.
    Kaldırım H; Yazgan S; Kırgız A; Atalay K; Savur F
    Curr Eye Res; 2019 Sep; 44(9):987-993. PubMed ID: 30983426
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema.
    Ercalik NY; Imamoglu S; Turkseven Kumral E; Yenerel NM; Bardak H; Bardak Y
    Cutan Ocul Toxicol; 2018 Dec; 37(4):324-327. PubMed ID: 29619858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of serous retinal detachment on the efficacy of ranibizumab in diabetic macular oedema.
    Qu-Knafo LM; Fajnkuchen F; Sarda V; Boubaya M; Levy V; Chaine G; Giocanti-Auregan A
    Acta Ophthalmol; 2017 Aug; 95(5):e434-e435. PubMed ID: 26823130
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of intravitreal ranibizumab, aflibercept and bevacizumab therapies in diabetic macular edema with serous retinal detachment.
    Sirakaya E; Kilic D; Aslan Sirakaya H
    Eur J Ophthalmol; 2023 May; 33(3):1459-1466. PubMed ID: 36482707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
    Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
    Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Giocanti-Aurégan A; Hrarat L; Qu LM; Sarda V; Boubaya M; Levy V; Chaine G; Fajnkuchen F
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):797-800. PubMed ID: 28152140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subfoveal Neurosensory Detachment Flattening and Observe (SNF-Ob): A Novel Approach in Diabetic Macular Edema Management: A Potential Cost-Effective Treatment Strategy to Be Explored.
    Sharma A; Parachuri N; Kumar N; Kuppermann BD; Bandello F; Loewenstein A; Regillo CD
    Ophthalmol Retina; 2019 Nov; 3(11):1009-1011. PubMed ID: 31451440
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
    Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
    J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY.
    Fickweiler W; Schauwvlieghe AME; Schlingemann RO; Maria Hooymans JM; Los LI; Verbraak FD;
    Retina; 2018 Apr; 38(4):812-819. PubMed ID: 28406860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of intravitreal ranibizumab and aflibercept on retinal vessel diameters in patients with diabetic macular edema.
    Aşikgarip N; Yenerel NM
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102282. PubMed ID: 33813015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).
    Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I
    Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Ashraf M
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1856. PubMed ID: 28358951
    [No Abstract]   [Full Text] [Related]  

  • 17. Ranibizumab for serous macular detachment in branch retinal vein occlusions.
    Gallego-Pinazo R; Dolz-Marco R; Pardo-López D; Martínez-Castillo S; Lleó-Pérez A; Arévalo JF; Díaz-Llopis M
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):9-14. PubMed ID: 22527327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
    Xu Y; Rong A; Xu W; Niu Y; Wang Z
    BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial.
    Furashova O; Strassburger P; Becker KA; Engelmann K
    BMC Ophthalmol; 2020 Jul; 20(1):308. PubMed ID: 32727496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of inner and outer retinal thickness in patients receiving intravitreal ranibizumab injections for diabetic macular edema.
    Dursun A; Ozec AV; Kirboga K; Dursun FG; Toker MI; Erdogan H; Arici MK
    Eur J Ophthalmol; 2016; 26(1):48-53. PubMed ID: 26220809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.